Our core is staffed by experts in immunohistochemistry (IHC), in situ hybridization (ISH), and multiplex fluorescence using multiple antibodies and/or probes. We offer routine protocols in these ...

The development of many different chromogens for light microscopy gives us the opportunity to explore different usage of multiplex immunohistochemistry (IHC) for clinical diagnostic purposes as well ...

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced the launch of its SignalStar Multiplex IHC ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ultivue today unveiled the expanded capabilities of its proprietary InSituPlex® DNA-barcoding and staining technology through comprehensive visualization of a whole ...

HalioDx, an immuno-oncology company pioneering the immunological diagnosis of cancers, announces the availability of Brightplex, a novel high capacity IHC multiplex technology enabling multiple ...

The prognostic value of Sprouty2 protein in nonsmall cell lung cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a full text component.

Multiplex immunohistochemistry (IHC) technologies are powerful tools to visualize multiple markers in the same tissue sample. These techniques, which include tyramide signal amplification and cyclic ...

Dublin, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The "Immunohistochemistry (IHC) Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global immunohistochemistry (IHC) ...

Nodal involvement and impact of adequate staging in older patients with resectable colon cancer: A population-based analysis. Targeted analysis of progressive metabolic perturbations in colorectal ...